Health Canada has granted authorization for both Moderna’s mRNA influenza vaccine and its combination mRNA vaccine targeting both flu and COVID-19 for adults 50 and older.
The federal health agency informed the company that its flu vaccine, mFLUSIVA, and its combined flu and COVID-19 shot, mCOFLU, received approval on Nov. 5, a Moderna spokesperson has confirmed.
The company said in a release it will engage with Canadian health authorities and immunization partners as it “advances plans for the future availability” of the shots in Canada.
Moderna’s mRNA flu shot received U.S. approval in August and Europe approved its combination vaccine last April, but Canada is the first country to authorize both of the vaccines, the company said….